Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Estrella Immunopharma (ESLA)
NASDAQ:ESLA
Holding ESLA?
Track your performance easily
ESLA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.63 - $3.23
Previous Close$1.15
Volume4.72K
Average Volume (3M)25.48K
Market Cap
$40.88M
Enterprise ValueN/A
Total Cash (Recent Filing)$478.87K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.33
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding36,179,146
10 Day Avg. Volume8,027
30 Day Avg. Volume25,480
Standard Deviation0.21
R-Squared0.01
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)817.65
Price to Cash Flow (P/CF)-4.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Estrella Immunopharma News
PremiumCompany Announcements
Estrella Immunopharma Appoints Dr. Cheng Liu as CEOPremiumCompany Announcements
Estrella Immunopharma Welcomes New Chairperson, Expands Board
PremiumCompany Announcements
Estrella Immunopharma Unveils Updated Investor PresentationOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.24% Mutual Funds
0.14% Other Institutional Investors
99.50% Public Companies and
Individual Investors
ESLA FAQ
What was Estrella Immunopharma’s price range in the past 12 months?
Estrella Immunopharma lowest stock price was $0.63 and its highest was $3.23 in the past 12 months.
What is Estrella Immunopharma’s market cap?
Estrella Immunopharma’s market cap is $40.88M.
When is Estrella Immunopharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Estrella Immunopharma’s earnings last quarter?
Currently, no data Available
Is Estrella Immunopharma overvalued?
According to Wall Street analysts Estrella Immunopharma’s price is currently Overvalued.
Does Estrella Immunopharma pay dividends?
Estrella Immunopharma does not currently pay dividends.
What is Estrella Immunopharma’s EPS estimate?
Estrella Immunopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Estrella Immunopharma have?
Estrella Immunopharma has 36,179,146 shares outstanding.
What happened to Estrella Immunopharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Estrella Immunopharma?
Currently, no hedge funds are holding shares in ESLA
---
Estrella Immunopharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
ESLA Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 255.0K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
-11.71%
12-Months-Change
Fundamentals
Return on Equity
-163.06%
Trailing 12-Months
Asset Growth
-86.34%
Trailing 12-Months
Company Description
Estrella Immunopharma
TradeUP Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
---
Technical Analysis
Agenus
―
Fate Therapeutics
―
Karyopharm Therapeutics
―
Blueprint Medicines
―
Adaptimmune Therapeutics
―
---